On ECHEMI
Home > Drugs > Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
Yangtze River Pharmaceutical Group Jiangsu HaiCi Biological Pharmaceutical Co., Ltd.
  • Founded in:

    2005-02-22
  • Country:

    China China
  • Address:

    No. 8, Taizhen Road, Taizhou Pharmaceutical Hi-tech Zone, Jiangsu Province
  • Tax NO.:

    91321200771524291U
  • Registered Funds:

    200 million yuan
  • Website:

  • Email:

Related Drugs
Tiopronin
Tiopronin.
Name Description Content CAS NO. Registered Holders
Tiopronin

Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.

More

Animal experiments have shown that this product can reduce the increase of serum AST and ALT in the animal acute liver injury model caused by TAA (thioacetamide) and CC14 (carbon tetrachloride), and inhibit the accumulation of triglycerides caused by chronic liver injury model; it can promote liver glycogen synthesis, inhibit the increase of cholesterol, and help the recovery of serum albumin/globulin ratio.

1953-02-2 55
Thymopentin
Name Description Content CAS NO. Registered Holders
Thymopentin

Extract from the above information

More

Extract from the above information

69558-55-0 41
Cefonicid Sodium
Name Description Content CAS NO. Registered Holders
Cefonicid sodium

No specific pharmacological information is provided

More

No specific pharmacological information is provided

61270-78-8 15
Terbinafine Hydrochloride
Name Description Content CAS NO. Registered Holders
Terbinafine Hydrochloride

78628-80-5 70
Cefpirome Sulfate
Name Description Content CAS NO. Registered Holders
Cefpirome sulfate

No specific pharmacological effects mentioned

More

No specific pharmacological effects mentioned

98753-19-6 40
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.